
In June 2003,
Los Angeles, California, researchers working at the
UCLA Olympic Analytical Laboratory received a package containing a spent syringe with traces of an unidentified compound of
anabolic steroid. This was originally sent anonymously to the
United States Anti-doping Agency. The researchers then quickly made some chemical test to deduce the chemical formula of the compound. They were able to synthesize a new compound, which they named as
tetrahydrogestrinone. The compound is quite similar to the previously banned
anabolic steroids gestrinone and
trenbolone.
Tetrahydrogestrinone (THG) is the second designer
anabolic steroid to be identified by then-director of the
UCLA Olympic Analytical Lab,
Don Catlin, MD. The first reported was
norbolethone.
THG was found to be a highly potent agonist for the androgen and progesterone receptors, but it has no estrogenic activity.
It was first developed by Patrick Arnold for the
American nutritional supplement company,
BALCO. It was also referred to as “The Clear” probably due to its concealment before 2003. Several
athletes like
Marion Jones, admitted to using it before the 2000 Sydney
Olympics. It gave her three gold medals. Another known user was
Dwaine Chambers, a British
athlete who was banned for
steroids use.
From
The Medical News:
In June 2003, a spent syringe having allegedly contained an undetectable anabolic steroid was anonymously provided to the United States Anti-Doping Agency (USADA), and the contents delivered to the research team in Los Angeles. The researchers, led by Don Catlin, detected an unfamiliar substance and deduced its chemical formula. They were then able to synthesize a compound with this formula, which they named tetrahydrogestrinone (THG) and which matched the unknown substance in the syringe.